Temasek Raises Health-Care Bets, Adds More ADRs of JD.comBy and
Singapore investment firm buys Illumina, Regeneron, Gilead
Firm’s assets rose to record as it boosted investments
Temasek Holdings Pte built holdings of U.S. drugmakers and health-care companies in the first quarter as the Singapore investment firm expands bets on industries that will benefit from rising life expectancies and a growing middle class in emerging markets.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.